Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.
about
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemiaHow I treat acquired aplastic anemiaPreventing stem cell transplantation-associated viral infections using T-cell therapyCurrent outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisBone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi AnemiaManagement of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
P2860
Q24201108-82C627D2-17CB-4744-B85A-EAEDBB86BB67Q24617687-AE3ECAE1-7921-4517-B461-E97B6972E402Q26801365-9DAA2231-5FDB-4A64-8272-195A3578433EQ35571068-2B5A9DD8-F13E-4AE6-A16F-26BE5537FA5DQ36133000-0BEDE8A8-8103-4CE2-B580-EA554ACF4A76Q36777485-321184CC-6155-49B7-87CF-B74F1116F57EQ37417561-F1C96066-A564-4917-AF28-3942E4A0DF3BQ38065878-4F13BA85-EA32-4B84-8AC3-4823D670A80CQ38103184-14519B0A-5C30-4E5B-9EC1-A83C4C35FB50Q38230343-111F3E26-82C8-4437-B820-66584C0A2534Q38261555-DC7856F0-B8BB-4A09-AD67-F1AFC5D8513DQ47126486-94752CF8-E76B-45E9-9E55-00DDE9DF119FQ47865904-5B0EF402-E1A3-4557-9860-3300479B20F5Q58782280-583E064C-97D3-4F92-9263-3EF14FE87A77
P2860
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@ast
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@en
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@nl
type
label
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@ast
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@en
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@nl
prefLabel
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@ast
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@en
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@nl
P2093
P2860
P50
P1476
Outcome of allogeneic hematopo ...... patients over 40 years of age.
@en
P2093
Dario Sangiolo
George Earl Georges
Hans-Peter Kiem
Kris Doney
Mary E D Flowers
Paul J Martin
Richard A Nash
Wendy M Leisenring
P2860
P304
P356
10.1016/J.BBMT.2010.04.005
P577
2010-04-18T00:00:00Z